Beth Smith's most recent trade in Macrogenics Inc was a trade of 93,750 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 93,750 | 93,750 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 15,625 | 15,625 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,095 | 0 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 1,095 | 13,204 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. | 12 Feb 2026 | 423 | 12,781 (0%) | 0% | 1.7 | 723 | Common Stock |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 2,617 | 5,233 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 2,617 | 12,149 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 1,583 | 12,721 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2026 | 1,583 | 1,584 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 07 Feb 2026 | 1,011 | 11,138 (0%) | 0% | 1.8 | 1,830 | Common Stock |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 07 Feb 2026 | 612 | 12,109 (0%) | 0% | 1.8 | 1,108 | Common Stock |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,095 | 1,095 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,095 | 9,955 (0%) | 0% | 0 | Common Stock | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Sale of securities on an exchange or to another person at price $ 2.56 per share. | 15 Feb 2025 | 423 | 9,532 (0%) | 0% | 2.6 | 1,083 | Common Stock |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 47,050 | 47,050 | - | - | Employee Stock Option (right to buy) | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 7,850 | 7,850 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 1,583 | 9,472 (0%) | 0% | - | Common Stock | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 1,583 | 3,167 | - | - | Restricted Stock Unit | |
| Macrogenics Inc | Beth Smith | VP, Controller & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 07 Feb 2025 | 612 | 8,860 (0%) | 0% | 2.6 | 1,591 | Common Stock |